Yukihiko Suzuki1, Hideaki Matsuhashi2, Mitsuru Nakazawa2. 1. Department of Ophthalmology, Hirosaki University School of Medicine, 5 Zaifu, 036-8562, Hirosaki, Japan. yukihiko@cc.hirosaki-u.ac.jp. 2. Department of Ophthalmology, Hirosaki University School of Medicine, 5 Zaifu, 036-8562, Hirosaki, Japan.
Abstract
PURPOSE: To perform in vivo cannulation of retinal vessels for local application of pharmacotherapy to treat central retinal vein occlusion (CRVO), a new method was tested using rabbits. Changes following cannulation were studied histologically. METHODS: The micropipette used for cannulation was constructed from a glass tube. The outer diameter of the tip was 30-40 microm. Rabbits for the experiment were anesthetized; each had its head stabilized with fixing equipment designed for that purpose. After preparing a port for infusion of balanced salt solution (BSS), the specially designed micropipette was inserted at the pars plana of the ciliary body to puncture the major retinal vein, through which BSS was injected. RESULTS: We were able to puncture the major retinal vein with the micropipette without causing any serious incident, after which we injected approximately 100 microl of BSS. A small amount of vitreous hemorrhage that appeared after removing the micropipette could be stopped by increasing intraocular pressure by elevating the infusion bottle. Postoperative observation by indirect ophthalmoscopy showed no obstruction in the vein at the puncture site. Light microscopy showed only a slight narrowing of the venous lumen at the site. CONCLUSION: Cannulation into the retinal vein of rabbits was possible, and invasion was not significant, as determined histologically. Our findings endorse a method of restoring blood flow that involves direct injection of tissue plasminogen activator into the retinal vein of patients with CRVO to dissolve a thrombus.
PURPOSE: To perform in vivo cannulation of retinal vessels for local application of pharmacotherapy to treat central retinal vein occlusion (CRVO), a new method was tested using rabbits. Changes following cannulation were studied histologically. METHODS: The micropipette used for cannulation was constructed from a glass tube. The outer diameter of the tip was 30-40 microm. Rabbits for the experiment were anesthetized; each had its head stabilized with fixing equipment designed for that purpose. After preparing a port for infusion of balanced salt solution (BSS), the specially designed micropipette was inserted at the pars plana of the ciliary body to puncture the major retinal vein, through which BSS was injected. RESULTS: We were able to puncture the major retinal vein with the micropipette without causing any serious incident, after which we injected approximately 100 microl of BSS. A small amount of vitreous hemorrhage that appeared after removing the micropipette could be stopped by increasing intraocular pressure by elevating the infusion bottle. Postoperative observation by indirect ophthalmoscopy showed no obstruction in the vein at the puncture site. Light microscopy showed only a slight narrowing of the venous lumen at the site. CONCLUSION: Cannulation into the retinal vein of rabbits was possible, and invasion was not significant, as determined histologically. Our findings endorse a method of restoring blood flow that involves direct injection of tissue plasminogen activator into the retinal vein of patients with CRVO to dissolve a thrombus.
Authors: John B Christoforidis; Scott M Warden; Massimo Demattia; Donald J D'Amico Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-01-18 Impact factor: 3.117
Authors: Marc D de Smet; Thijs C M Meenink; Tom Janssens; Valerie Vanheukelom; Gerrit J L Naus; Maarten J Beelen; Caroline Meers; Bart Jonckx; Jean-Marie Stassen Journal: PLoS One Date: 2016-09-27 Impact factor: 3.240